(Q44125980)

30 November 2017

Novel glycosaminoglycan precursors as anti-amyloid agents part II. (English)

1 reference

30 November 2017

Robert Kisilevsky

1

1 reference

PubMed ID

12212792

30 November 2017

Walter A Szarek

series ordinal

2

1 reference

30 November 2017

1 August 2002

1 reference

Journal of Molecular Neuroscience

30 November 2017

1 reference

30 November 2017

19

1 reference

30 November 2017

45-50

1 reference

30 November 2017

1-2

1 reference

https://scigraph.springernature.com/pub.10.1007/s12031-002-0009-3

30 November 2017

0 references

cites work

Structure of heparan sulphate from human brain, with special regard to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0009-3

Circular-dichroism studies on two murine serum amyloid A proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0009-3

A sulfated proteoglycan aggregation factor mediates amyloid-beta peptide fibril formation and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0009-3

Classification of amyloid fibril proteins and their precursors: An ongoing discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-002-0009-3

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Biosynthesis of heparin and heparan sulfate

1 reference

12 December 2020

Effects of Culture Substrates and Normal Hepatic Sinusoidal Cells on in Vitro Hepatocyte Synthesis of Apo-SAA

1 reference

12 December 2020

Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation

1 reference

12 December 2020

A beta amyloidogenesis: unique, or variation on a systemic theme?

1 reference

12 December 2020

Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth

1 reference

12 December 2020

Influence of monosaccharide derivatives on liver cell glycosaminoglycan synthesis: 3-deoxy-D-xylo-hexose (3-deoxy-D-galactose) and methyl (methyl 4-chloro-4-deoxy-beta-D-galactopyranosid) uronate

1 reference

12 December 2020

Selective loss of cerebral keratan sulfate in Alzheimer's disease.

1 reference

12 December 2020

Common binding sites for beta-amyloid fibrils and fibroblast growth factor-2 in heparan sulfate from human cerebral cortex

1 reference

12 December 2020

The heparin/heparan sulfate-binding site on apo-serum amyloid A. Implications for the therapeutic intervention of amyloidosis.

1 reference

12 December 2020

Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose and their effects on cellular glycosaminoglycan biosynthesis

1 reference

12 December 2020

Amyloid-specific heparan sulfate from human liver and spleen

1 reference

12 December 2020

Synthesis of 4-deoxy analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-xylose and their effects on glycoconjugate biosynthesis

1 reference

12 December 2020

10.1007/S12031-002-0009-3

Identifiers

DOI

1 reference

30 November 2017

1 reference

PubMed ID

12212792